Temporal trends in hypersensitivity pneumonitis–coded mortality: a multinational analysis of 32 countries, 1999–2019

This is the authors' abstract. We don't add key points for this paper.

Contemporary evidence on hypersensitivity pneumonitis (HP) mortality trends remains limited. Using World Health Organization Mortality Database data (ICD-10: J67) from 32 countries, we analyzed 7,581 deaths in adults aged ≥ 20 years between 1999 and 2019. Age-standardized mortality rates (ASMRs) were calculated using the WHO World Standard Population; joinpoint regression estimated annual and average annual percent changes (APC, AAPC), and Kitagawa decomposition separated the contributions of population age structure and age-specific mortality rates. The pooled ASMR was 0.0394 per 100,000 (95% CI 0.0385–0.0403). HP-coded mortality was stable from 1999 to 2004 and rose thereafter (APC 7.34%; 95% CI 6.66–8.02), giving an AAPC of 5.43% (95% CI 4.35–6.52). HP-coded mortality was higher in men (0.0496 versus 0.0317 per 100,000), increased more steeply in women (AAPC 6.40% versus 4.45%) and rose with age to 0.2977 per 100,000 at ≥ 80 years. Among the 25 countries with ≥ 30 deaths, eight showed a significant increase and two a significant decrease. Population aging accounted for 12.2% of the increase in crude mortality among adults aged ≥ 40 years. HP-coded mortality increased across this multinational sample with substantial between-country heterogeneity, which may reflect changes in diagnostic recognition and certification practice as well as in disease occurrence.